Series B - CureGenetics
Investment Firm
Overview
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Announced Date
Jan 05, 2022
Funding Type
Series B
Highlights
N/A
Location
N/A
Social
N/A
Participant Investors
4
Round Details and Background
CureGenetics raised $60000000 on 2022-01-05 in Series B
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 06, 2018 | 4 | - | 17.0M | |
| Mar 19, 2020 | 1 | - | 9.5M | |
| Jan 05, 2022 | 4 | - | 60.0M | |
| Mar 28, 2024 | 1 | - | 9.0M |
Recent Activity
There is no recent news or activity for this profile.